您的位置: 首页 > 农业专利 > 详情页

MÉTHODE DE TRAITEMENT DES ÉTATS RÉAGISSANT À LA BENDAMUSTINE CHEZ DES PATIENTS NÉCESSITANT DES VOLUMES RÉDUITS POUR L'ADMINISTRATION
专利权人:
INC.;EAGLE PHARMACEUTICALS
发明人:
SUNDARAM, SRIKANTH,TARRIFF, SCOTT, L.
申请号:
EP13765020
公开号:
EP2827863A4
申请日:
2013.03.15
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充